Skip to main content

Table 1 Visual and quantitative parameters for disease states

From: Interpreting 123I–ioflupane dopamine transporter scans using hybrid scores

  ET
(N = 34)
PD
(N = 85)
MA
(N = 6)
DLB
(N = 7)
ANOVA
F-ratio
Visual 0.81 ± 0.86 1.77 ± 0.55* 2.00 ± 0.00* 1.86 ± 0.38* 18.9
CSBR 2.08 ± 0.52 1.30 ± 0.54* 0.53 ± 0.23*† 0.80 ± 0.25*† 28.5
PSBR 1.24 ± 0.42 0.51 ± 0.36* 0.22 ± 0.17*† 0.28 ± 0.18*† 38.9
CAQ 5.34 ± 2.04 3.8 ± 1.76* 1.81 ± 1.39*† 1.94 ± 1.12*† 12.1
PAQ 2.11 ± 1.06 0.94 ± 0.61* 0.59 ± 0.49* 0.45 ± 0.40*† 23.8
Indexed Visual 0.18 ± 0.19 0.39 ± 0.13* 0.44 ± 0.02* 0.44 ± 0.09*† 17.2
Indexed CSBR 0.42 ± 0.11 0.25 ± 0.11* 0.10 ± 0.04* 0.16 ± 0.05* 29.7
Indexed PSBR 0.28 ± 0.09 0.11 ± 0.08* 0.05 ± 0.04* 0.07 ± 0.05* 41.2
Indexed CAQ 5.31 ± 1.09 3.67 ± 1.67* 1.74 ± 1.34*† 1.98 ± 1.11*† 13.2
Indexed PAQ 2.38 ± 1.27 1.02 ± 1.27* 0.64 ± 1.27* 0.53 ± 0.48*† 24.3
  1. ET essential tremor, PD Parkinson’s disease, MA multiple system atrophy, DLB dementia with Lewy bodies, ANOVA analysis of variance, C SBR caudate specific binding ratio, P SBR putamen specific binding ratio, CAQ minimum caudate absolute quantitative uptake, PAQ minimum putamen absolute quantitative uptake
  2. * p < 0.05 versus ET; † p < 0.05 versus PD